HbA1c is used as a gold standard to see whether patients have optimal glycemic control. Today, many physicians rely solely on HbA1c to change medication. However, there is a select group of patients that have low average glucose levels but high HbA1c levels. The investigators believe that these patients are fast glycators meaning that they incorporate sugar into their hemoglobin faster than normal. The investigators want to determine whether these patients are fast glycators.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
25
The subjects enrolled in this study will have a fructosamine test and blood drawn to see whether they are fast glycators
These patients will have their blood drawn to know what the normal glycation rate is in diabetic patients
Primary endpoint is to see whether they are fast glycators
Time frame: One Week
A secondary endpoint includes adverse events such as unplanned hospitalizations for any cause that last more than 24 hours
Time frame: One Week
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.